missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant SARS-CoV-2 B.1.617.1 S Alexa Fluor™ 647 Protein
Click to view available options
:
20 μg
Description
Measured by flow cytometry for its ability to bind HEK293 human embryonic kidney cells transfected with human ACE-2 at 0.25-1.00 μg/mL (100 μL/well). Please Note: Optimal dilutions should be determined by each laboratory for each application.
Specifications
Specifications
| Accession Number | YP_009724390.1 |
| For Use With (Application) | Bioactivity |
| Formulation | Supplied as a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
| Gene ID (Entrez) | 43740568 |
| Molecular Weight (g/mol) | M.W.-theroretical: 138 kDa, M.W.-observed: 139-167 kDa, under reducing conditions. |
| Quantity | 20 μg |
| Source | Human embryonic kidney cell, HEK293-derived sars-cov-2 Spike protein Recombinant SARS-CoV-2 Spike (Val16-Lys1211)(Gly142Asp, Glu154Lys, Leu452Arg, Glu484Gln, Asp614Gly, Pro681Arg, Gln1071His)(Arg682Ser, Arg685Ser, Lys986Pro, Val987Pro) (c-terminus) Accession # YP_009724390.1 GCN4-IZ 6-His tag N-terminus C-terminμs |
| Storage Requirements | Protect from light. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after opening. 3 months, -20°C to -70°C under sterile conditions after opening. |
| Endotoxin Concentration | <1.0 EU / 1 μg of the protein by the LAL method. |
| Gene Alias | 2019-nCoV S Protein, 2019-nCoV Spike, COVID-19 Spike, E2, Human coronavirus spike glycoprotein, Peplomer protein, S glycoprotein, S Protein, SARS-CoV-2, SARS-COV-2 S protein, SARS-COV-2 Spike glycoprotein, SARSCOV2 Spike protein, Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein, Spike glycoprotein, surface glycoprotein |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction